Laura Sepp-Lorenzino

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Kamran Alam, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Laura Sepp-Lorenzino:

Company Role Class Num Shares Value Price $ Report Date Ownership
Intellia Therapeutics, Inc. EVP, Chief Scientific Officer Common Stock 77,388 $942,586 $12.18 03 Jan 2025 Direct
Taysha Gene Therapies, Inc. Director Common Stock 105,843 $245,555 $2.32 02 Jun 2025 Direct
Taysha Gene Therapies, Inc. Director Stock Option (right to buy) 113,246 02 Jun 2025 Direct
Intellia Therapeutics, Inc. EVP, Chief Scientific Officer Stock Option (right to buy) 54,794 01 Mar 2024 Direct
Intellia Therapeutics, Inc. EVP, Chief Scientific Officer Restricted Stock Unit 0 01 Jan 2025 Direct

Insider Reports Filed by Laura Sepp-Lorenzino

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TSHA Taysha Gene Therapies, Inc. 02 Jun 2025 2 $0 4 Director 04 Jun 2025, 16:15
NTLA Intellia Therapeutics, Inc. 03 Jan 2025 1 -$109,206 4 EVP, Chief Scientific Officer 07 Jan 2025, 17:16
NTLA Intellia Therapeutics, Inc. 01 Jan 2025 2 $0 4 EVP, Chief Scientific Officer 03 Jan 2025, 16:30
TSHA Taysha Gene Therapies, Inc. 29 May 2024 2 $0 4 Director 31 May 2024, 16:15
NTLA Intellia Therapeutics, Inc. 01 Mar 2024 2 $0 4 EVP, Chief Scientific Officer 05 Mar 2024, 16:10
NTLA Intellia Therapeutics, Inc. 08 Jan 2024 2 -$65,682 4 EVP, Chief Scientific Officer 10 Jan 2024, 16:15
NTLA Intellia Therapeutics, Inc. 03 Jan 2024 1 -$162,973 4 EVP, Chief Scientific Officer 05 Jan 2024, 16:50
NTLA Intellia Therapeutics, Inc. 01 Jan 2024 2 $0 4 EVP, Chief Scientific Officer 03 Jan 2024, 17:35
TSHA Taysha Gene Therapies, Inc. 22 Jun 2023 1 $0 4 Director 26 Jun 2023, 16:50
NTLA Intellia Therapeutics, Inc. 01 Mar 2023 2 $0 4 EVP, Chief Scientific Officer 03 Mar 2023, 16:14
NTLA Intellia Therapeutics, Inc. 04 Jan 2023 3 -$182,982 4 EVP, Chief Scientific Officer 06 Jan 2023, 16:39
NTLA Intellia Therapeutics, Inc. 01 Jan 2023 2 $0 4 EVP, Chief Scientific Officer 04 Jan 2023, 19:38
TSHA Taysha Gene Therapies, Inc. 17 Jun 2022 1 $0 4 Director 22 Jun 2022, 16:41
NTLA Intellia Therapeutics, Inc. 01 Mar 2022 1 $0 4/A EVP, Chief Scientific Officer 04 Mar 2022, 19:58
NTLA Intellia Therapeutics, Inc. 01 Jan 2022 5 -$128,863 4 EVP, Chief Scientific Officer 03 Mar 2022, 19:03
NTLA Intellia Therapeutics, Inc. 30 Aug 2021 13 -$13,658,754 4 EVP, Chief Scientific Officer 01 Sep 2021, 19:34
NTLA Intellia Therapeutics, Inc. 04 Aug 2021 9 -$3,245,957 4 EVP, Chief Scientific Officer 06 Aug 2021, 18:19
TSHA Taysha Gene Therapies, Inc. 17 Jun 2021 1 $0 4 Director 21 Jun 2021, 17:01